Phibro Animal Health Corporation
NASDAQ: PAHC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jack Clifford Bendheim
- Employees
- 1,940
- Headquarters
- Teaneck, United States
- IPO year
- 2014
- Market cap
- $1.3B
- Website
- https://www.pahc.com
Loading PAHC…
Loading profile data…Frequently asked questions about PAHC
What does Phibro Animal Health Corporation (PAHC) do?
Phibro Animal Health Corporation operates as a global entity focused on the research, production, and supply of a wide array of animal health and mineral nutrition solutions. While serving a global clientele, its primary market for livestock products is the United States. The company's operations are divided into three main business segments: An...
Where does PAHC trade?
Phibro Animal Health Corporation (PAHC) trades on the NASDAQ Global Market.
What sector is PAHC in?
Phibro Animal Health Corporation (PAHC) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Phibro Animal Health Corporation?
Jack Clifford Bendheim is the chief executive officer of Phibro Animal Health Corporation (PAHC).
Where is Phibro Animal Health Corporation headquartered?
Phibro Animal Health Corporation is headquartered in United States.
Does PAHC pay a dividend?
Yes — Phibro Animal Health Corporation (PAHC) paid a trailing twelve-month dividend of USD 0.48 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did PAHC go public?
Phibro Animal Health Corporation (PAHC) completed its initial public offering in 2014.